capmatinib Report issue

Small molecule Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Incyte is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.   Wikipedia

  • SMILES: CNC(=O)c1ccc(cc1F)c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2
  • InChIKey: LIOLIMKSCNQPLV-UHFFFAOYSA-N
  • Mol. Mass: 412.43
  • ALogP: 3.43
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$119.8795 - $158.6571
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

capmatinib | inc280 | inc-280 | incb028060 | incb-28060 | nvp-inc280

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue